Geert Vandeweyer

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 8

Top Venues

Journal of translational medicine

Nature reviews. Clinical oncology

Cell cycle (Georgetown, Tex.)

Molecular genetics and genomics : MGG

University of Antwerp

Universiteit Antwerpen (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Antwerp Oct 01 2013 - Apr 15 2020

Belgium

FWO Post-Doc, Bio-Informatics :: Department of Medical Genetics

Universiteit Antwerpen

Belgium

Post Doctoral Researcher in Bio-Informatics :: Department of Medical Genetics

Education History

Universiteit Antwerpen

Belgium

PHD :: Department of Medical Genetics

Katholieke Universiteit Leuven Sep 01 2006 - Jun 30 2007

Belgium

MSC

Publications

Marc Terrones, Christophe Deben, Felicia Rodrigues-Fortes, Anne Schepers, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer
CRISPR/Cas9-edited ROS1 + non-small cell lung cancer cell lines highlight differential drug sensitivity in 2D vs 3D cultures while reflecting established resistance profiles. Journal of translational medicine 22 (1) (2024)
Marc Terrones, Christophe Deben, Felicia Rodrigues-Fortes, Anne Schepers, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer
CRISPR/Cas9-edited ROS1 + non-small cell lung cancer cell lines highlight differential drug sensitivity in 2D vs 3D cultures while reflecting established resistance profiles. Journal of translational medicine 22 (1) (2024)
Marc Terrones, Christophe Deben, Felicia Rodrigues-Fortes, Anne Schepers, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer
CRISPR/Cas9-edited ROS1 + non-small cell lung cancer cell lines highlight differential drug sensitivity in 2D vs 3D cultures while reflecting established resistance profiles. Journal of translational medicine 22 (1) (2024)
Marc Terrones, Christophe Deben, Felicia Rodrigues-Fortes, Anne Schepers, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer
CRISPR/Cas9-edited ROS1 + non-small cell lung cancer cell lines highlight differential drug sensitivity in 2D vs 3D cultures while reflecting established resistance profiles. Journal of translational medicine 22 (1) (2024)
Merel Hennink, Geert Vandeweyer, Janet Freeman-Daily, null null
The roles of patient groups in fostering cancer research. Nature reviews. Clinical oncology 17 (2) (2020)
Shweta Kalve, Bulelani L Sizani, Marios Nektarios Markakis, Céline Helsmoortel, Geert Vandeweyer, Kris Laukens, Manou Sommen, Stefan Naulaerts, Kris Vissenberg, Els Prinsen, Gerrit T S Beemster
Osmotic stress inhibits leaf growth of Arabidopsis thaliana by enhancing ARF-mediated auxin responses. The New phytologist 226 (6) (2020)
Hanne Valgaeren, Manou Sommen, Matthias Beyens, Geert Vandeweyer, Isabelle Schrauwen, Anne Schepers, Isabelle Schatteman, Vedat Topsakal, Ingeborg Johanna Maria Dhooge, Henricus P M Kunst, Diego Zanetti, Alexander M Huber, Alexander Hoischen, Erik Fransen, Guy Van Camp
Insufficient evidence for a role of SERPINF1 in otosclerosis. Molecular genetics and genomics : MGG 294 (4) (2019)
Elisa Cappuyns, Jolien Huyghebaert, Geert Vandeweyer, R Frank Kooy
Mutations in ADNP affect expression and subcellular localization of the protein. Cell cycle (Georgetown, Tex.) 17 (9) (2018)

Geert Vandeweyer.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Geert Vandeweyer